Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.

Journal

Blood cancer journal
ISSN: 2044-5385
Titre abrégé: Blood Cancer J
Pays: United States
ID NLM: 101568469

Informations de publication

Date de publication:
28 Feb 2019
Historique:
entrez: 2 3 2019
pubmed: 2 3 2019
medline: 2 3 2019
Statut: epublish

Résumé

Since the publication of the original article the authors noticed the the affiliation details for Paresh Vyas are incorrect. The correct affiliation details for this author are given below.

Identifiants

DOI: 10.1038/s41408-019-0190-z PMID: 30820024 PMC: PMC6395678
pubmed: 30820024
doi: 10.1038/s41408-019-0190-z
pii: 10.1038/s41408-019-0190-z
pmc: PMC6395678
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

28

Commentaires et corrections

Type : ErratumFor

Auteurs

Miriam Marquis (M)

The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.
The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.

Cyrielle Beaubois (C)

The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.
The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.

Vincent-Philippe Lavallée (VP)

The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.
ORCID: 0000-0001-9095-0066

Michal Abrahamowicz (M)

Epidemiology and Biostatistics Department, McGill University, Montréal, Canada.

Coraline Danieli (C)

Epidemiology and Biostatistics Department, McGill University, Montréal, Canada.

Sébastien Lemieux (S)

The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
Department of Computer Science and Operations Research, Université de Montréal, Montréal, Canada.
ORCID: 0000-0001-5477-1386

Imran Ahmad (I)

Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.

Andrew Wei (A)

Department of Haematology, Alfred Hospital, Melbourne, Australia.
Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.

Stephen B Ting (SB)

Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Department of Haematology, Eastern Health, Box Hill Hospital, Melbourne, Australia.

Shaun Fleming (S)

Department of Haematology, Alfred Hospital, Melbourne, Australia.

Anthony Schwarer (A)

Department of Haematology, Eastern Health, Box Hill Hospital, Melbourne, Australia.

David Grimwade (D)

Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, King's College London, London, UK.
UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.

William Grey (W)

Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, King's College London, London, UK.
ORCID: 0000-0001-8209-5645

Robert K Hills (RK)

UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.
Centre for Trials Research, Cardiff University School of Medicine, Cardiff, UK.

Paresh Vyas (P)

MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford, UK.

Nigel Russell (N)

UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.
Centre for Clinical Haematology, Nottingham University Hospital (City Hospital Campus), Nottingham, UK.

Guy Sauvageau (G)

The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.
The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.

Josée Hébert (J)

The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada. josee.hebert@umontreal.ca.
The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada. josee.hebert@umontreal.ca.
Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada. josee.hebert@umontreal.ca.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada. josee.hebert@umontreal.ca.

Classifications MeSH